{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T21:19:44Z","timestamp":1782422384988,"version":"3.54.5"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>In 2005, the \u201cJapanese Research Committee on Severe Cutaneous Adverse Reaction\u201d (J-SCAR) presented the official \u201cDiagnostic Criteria\u201d for SJS\/TEN, and the specific ocular findings are included in these very important criteria. In SJS\/TEN cases involving ocular disorder, conjunctivitis often occurs prior to the onset of the high fever. In a Japanese survey, ocular involvement was observed in 77% of the cases, and the incidence of ocular sequelae increased depending on the score of the acute ocular severity findings. Pseudo-membrane formation and epithelial defects are considered to be high-risk signs of ocular sequelae. At the chronic stage, limbal stem cell deficiency, visual disturbance, and severe dryness of the ocular surface are the primary disease characteristics. In 2002, we started performing Cultivated Oral Mucosal Epithelial Transplantation (COMET) for the treatment of severe ocular disorders, including SJS\/TEN. As an additional treatment method, we developed a new type of rigid contact lens (CL) that is 13 to 14.0-mm in diameter, known as the \u201cLimbal Rigid Contact Lens (Limbal CL).\u201d Our Limbal Rigid CL greatly enhances the postoperative outcome of COMET. The detection rate of ocular surface bacteria is high in SJS\/TEN cases. Thus, appropriate use of topical antibiotics reduces the risk of ocular surface inflammation. Moreover, rebamipide is an ophthalmic solution for dry eye that was developed in Japan, and it also has the effect of suppressing ocular surface inflammation. From disease onset until the chronic stage, the control of inflammation and stem cell loss is key to successfully treating eyes afflicted with SJS\/TEN.<\/jats:p>","DOI":"10.3389\/fmed.2021.657327","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T05:58:10Z","timestamp":1627451890000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Japan: Diagnosis and Management of Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis With Severe Ocular Complications"],"prefix":"10.3389","volume":"8","author":[{"given":"Chie","family":"Sotozono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Ueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"28S","DOI":"10.1111\/1523-1747.ep12388434","article-title":"The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification","volume":"102","author":"Roujeau","year":"1994","journal-title":"J Invest Dermatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","article-title":"Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study","volume":"138","author":"Auquier-Dunant","year":"2002","journal-title":"Arch Dermatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ajo.2015.05.002","article-title":"Predictive factors associated with acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"160","author":"Sotozono","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1111\/aos.12397","article-title":"Cultivated oral mucosal epithelial transplantation for persistent epithelial defect in severe ocular surface diseases with acute inflammatory activity","volume":"92","author":"Sotozono","year":"2014","journal-title":"Acta Ophthalmol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.ophtha.2004.11.035","article-title":"Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome","volume":"112","author":"Di Pascuale","year":"2005","journal-title":"Ophthalmology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ophtha.2006.10.029","article-title":"New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome","volume":"114","author":"Sotozono","year":"2007","journal-title":"Ophthalmology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ophtha.2008.12.048","article-title":"Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications","volume":"116","author":"Sotozono","year":"2009","journal-title":"Ophthalmology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/2042098611404094","article-title":"Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality","volume":"2","author":"Roujeau","year":"2011","journal-title":"Ther Adv Drug Saf."},{"key":"B10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3341\/kjo.2013.27.5.331","article-title":"Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome","volume":"27","author":"Kim","year":"2013","journal-title":"Korean J Ophthalmol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.ajo.2008.12.040","article-title":"Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset","volume":"147","author":"Araki","year":"2009","journal-title":"Am J Ophthalmol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1136\/bjo.2010.196295","article-title":"Cytokine storm arising on the ocular surface in a patient with Stevens-Johnson syndrome","volume":"95","author":"Yagi","year":"2011","journal-title":"Br J Ophthalmol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/bjo.83.4.399","article-title":"Amniotic membrane transplantation for ocular surface reconstruction","volume":"83","author":"Azuara-Blanco","year":"1999","journal-title":"Br J Ophthalmol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.ophtha.2005.05.022","article-title":"Evaluation of amniotic membrane transplantation as an adjunct to medical therapy as compared with medical therapy alone in acute ocular burns","volume":"112","author":"Tamhane","year":"2005","journal-title":"Ophthalmology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1136\/bjo.2006.098525","article-title":"Amniotic membrane transplantation for ocular disease: a review of the first 233 cases from the UK user group","volume":"91","author":"Saw","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0161-6420(01)00694-7","article-title":"Cultivated corneal epithelial stem cell transplantation in ocular surface disorders","volume":"108","author":"Koizumi","year":"2001","journal-title":"Ophthalmology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1542-0124(12)70021-6","article-title":"Concept and clinical application of cultivated epithelial transplantation for ocular surface disorders","volume":"2","author":"Kinoshita","year":"2004","journal-title":"Ocul Surf."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/S0161-6420(95)30811-1","article-title":"Analysis of the acute ophthalmic manifestations of the erythema multiforme\/Stevens-Johnson syndrome\/toxic epidermal necrolysis disease spectrum","volume":"102","author":"Power","year":"1995","journal-title":"Ophthalmology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1136\/bjo.84.10.1191","article-title":"Conjunctival inflammation in the chronic phase of Stevens-Johnson syndrome","volume":"84","author":"Kawasaki","year":"2000","journal-title":"Br J Ophthalmol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"18922","DOI":"10.1038\/s41598-020-76064-8","article-title":"Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"10","author":"Yoshikawa","year":"2020","journal-title":"Sci Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1097\/01.ico.0000263127.84015.3f","article-title":"Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea","volume":"21","author":"Sotozono","year":"2002","journal-title":"Cornea."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e001206","DOI":"10.1136\/bmjopen-2012-001206","article-title":"Vancomycin Ophthalmic Ointment 1% for methicillin-resistant Staphylococcus aureus or methicillin-resistant Staphylococcus epidermidis infections: a case series","volume":"3","author":"Sotozono","year":"2013","journal-title":"BMJ Open."},{"key":"B23","doi-asserted-by":"publisher","first-page":"DES80","DOI":"10.1167\/iovs.18-24019","article-title":"Severe dry eye with combined mechanisms is involved in the ocular sequelae of SJS\/TEN at the chronic stage","volume":"59","author":"Sotozono","year":"2018","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ajo.2013.11.010","article-title":"A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye","volume":"157","author":"Kinoshita","year":"2014","journal-title":"Am J Ophthalmol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.ophtha.2012.12.022","article-title":"A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye","volume":"120","author":"Kinoshita","year":"2013","journal-title":"Ophthalmology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1089\/jop.2012.0054","article-title":"Rebamipide suppresses PolyI:C-stimulated cytokine production in human conjunctival epithelial cells","volume":"29","author":"Ueta","year":"2013","journal-title":"J Ocul Pharmacol Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0002-9394(14)70510-0","article-title":"Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome","volume":"122","author":"Tsubota","year":"1996","journal-title":"Am J Ophthalmol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/S0161-6420(97)30057-8","article-title":"Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns","volume":"104","author":"Shimazaki","year":"1997","journal-title":"Ophthalmology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1167\/iovs.02-0195","article-title":"The successful culture and autologous transplantation of rabbit oral mucosal epithelial cells on amniotic membrane","volume":"44","author":"Nakamura","year":"2003","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1136\/bjo.2003.038497","article-title":"Transplantation of cultivated autologous oral mucosal epithelial cells in patients with severe ocular surface disorders","volume":"88","author":"Nakamura","year":"2004","journal-title":"Br J Ophthalmol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ajo.2005.09.003","article-title":"Midterm results on ocular surface reconstruction using cultivated autologous oral mucosal epithelial transplantation","volume":"141","author":"Inatomi","year":"2006","journal-title":"Am J Ophthalmol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ajo.2006.06.004","article-title":"Ocular surface reconstruction with combination of cultivated autologous oral mucosal epithelial transplantation and penetrating keratoplasty","volume":"142","author":"Inatomi","year":"2006","journal-title":"Am J Ophthalmol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1001\/archopht.124.11.1543","article-title":"Autologous serum-derived cultivated oral epithelial transplants for severe ocular surface disease","volume":"124","author":"Ang","year":"2006","journal-title":"Arch Ophthalmol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1097\/00003226-200310001-00011","article-title":"Ocular surface reconstruction using cultivated mucosal epithelial stem cells","volume":"22","author":"Nakamura","year":"2003","journal-title":"Cornea."},{"key":"B35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ophtha.2012.07.053","article-title":"Visual improvement after cultivated oral mucosal epithelial transplantation","volume":"120","author":"Sotozono","year":"2013","journal-title":"Ophthalmology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1136\/bjo.2010.188714","article-title":"Long-term results of autologous cultivated oral mucosal epithelial transplantation in the scar phase of severe ocular surface disorders","volume":"95","author":"Nakamura","year":"2011","journal-title":"Br J Ophthalmol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/01.iop.0000440709.90516.87","article-title":"Folliculitis in clinically \u201cquiet\u201d chronic Stevens-Johnson syndrome","volume":"30","author":"Watanabe","year":"2014","journal-title":"Ophthalmic Plast Reconstr Surg."},{"key":"B38","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.ajo.2014.07.012","article-title":"Tear exchangeable limbal rigid contact lens for ocular sequelae resulting from Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"158","author":"Sotozono","year":"2014","journal-title":"Am J Ophthalmol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.clae.2020.05.007","article-title":"Clinical trial to evaluate the therapeutic benefits of limbal-supported contact lens wear for ocular sequelae due to Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"43","author":"Itoi","year":"2020","journal-title":"Cont Lens Anterior Eye."},{"key":"B40","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1097\/ICO.0000000000002566","article-title":"Oral mucosal epithelial transplantation and limbal-rigid contact lens: a therapeutic modality for the treatment of severe ocular surface disorders","volume":"39","author":"Sotozono","year":"2020","journal-title":"Cornea."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.657327\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T05:58:13Z","timestamp":1627451893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.657327\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,28]]},"references-count":40,"alternative-id":["10.3389\/fmed.2021.657327"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.657327","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,28]]},"article-number":"657327"}}